SCHEDULE OF SHARE BASED CONSULTING ADVISORY AWARDS AND RELATED COMPENSATION EXPENSE RECOGNIZED (Details) |
12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
shares
| ||||||||||||||||||
| Consulting And Advisory Agreement [Member] | ||||||||||||||||||
| Expense | $ 805,635 | |||||||||||||||||
| Looi Pei See [Member] | ||||||||||||||||||
| Shares | shares | 1,140,000 | [1] | ||||||||||||||||
| Grant Date | Dec. 31, 2022 | [1] | ||||||||||||||||
| Stock price | $ / shares | $ 0.2000 | [1] | ||||||||||||||||
| Grant-Date Fair Value | $ 228,000 | [1] | ||||||||||||||||
| Service Period / Award Terms | Issued in advance of service period; 12/15/2022 to 12/14/2025 | [1] | ||||||||||||||||
| Expense | $ 34,741 | [1] | ||||||||||||||||
| Donald R. Fosnacht [Member] | ||||||||||||||||||
| Shares | shares | 1,000,000 | [2] | ||||||||||||||||
| Grant Date | Jan. 31, 2024 | [2] | ||||||||||||||||
| Stock price | $ / shares | $ 0.1340 | [2] | ||||||||||||||||
| Grant-Date Fair Value | $ 134,000 | [2] | ||||||||||||||||
| Service Period / Award Terms | Issued in advance of service period through 12/31/2025 | [2] | ||||||||||||||||
| Expense | $ 30,782 | [2] | ||||||||||||||||
| Dr Raymond Powell [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | ||||||||||||||||||
| Shares | shares | 1,000,000 | [3] | ||||||||||||||||
| Grant Date | Jul. 01, 2025 | [3] | ||||||||||||||||
| Stock price | $ / shares | $ 0.0950 | [3] | ||||||||||||||||
| Grant-Date Fair Value | $ 95,000 | [3] | ||||||||||||||||
| Service Period / Award Terms | Second tranche service period; 5/1/2025 to 4/30/2026 | [3] | ||||||||||||||||
| Expense | $ 79,123 | [3] | ||||||||||||||||
| Dr Raymond Powell [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | ||||||||||||||||||
| Shares | shares | [3] | |||||||||||||||||
| Grant Date | [3] | |||||||||||||||||
| Stock price | $ / shares | [3] | |||||||||||||||||
| Grant-Date Fair Value | $ 100,000 | [3] | ||||||||||||||||
| Service Period / Award Terms | Third tranche fixed-dollar award for service period; 5/1/2026 to 4/30/2027. Shares not issued as of 6/30/2026 | [3] | ||||||||||||||||
| Expense | $ 16,712 | [3] | ||||||||||||||||
| Dr Nam Tran [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | ||||||||||||||||||
| Shares | shares | 1,727,115 | [3] | ||||||||||||||||
| Grant Date | Jan. 05, 2026 | [3] | ||||||||||||||||
| Stock price | $ / shares | $ 0.0579 | [3] | ||||||||||||||||
| Grant-Date Fair Value | $ 100,000 | [3] | ||||||||||||||||
| Service Period / Award Terms | Second tranche fixed-dollar award for service period; 5/1/2025 to 4/30/2026 | [3] | ||||||||||||||||
| Expense | $ 83,288 | [3] | ||||||||||||||||
| Dr Nam Tran [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | ||||||||||||||||||
| Shares | shares | [3] | |||||||||||||||||
| Grant Date | [3] | |||||||||||||||||
| Stock price | $ / shares | [3] | |||||||||||||||||
| Grant-Date Fair Value | $ 100,000 | [3] | ||||||||||||||||
| Service Period / Award Terms | Third tranche fixed-dollar award for service period; 5/1/2026 to 4/30/2027. Shares not issued as of 6/30/2026 | [3] | ||||||||||||||||
| Expense | $ 16,712 | [3] | ||||||||||||||||
| Dale Ludwig [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | ||||||||||||||||||
| Shares | shares | 1,727,115 | [4] | ||||||||||||||||
| Grant Date | Jan. 05, 2026 | [4] | ||||||||||||||||
| Stock price | $ / shares | $ 0.0579 | [4] | ||||||||||||||||
| Grant-Date Fair Value | $ 100,000 | [4] | ||||||||||||||||
| Service Period / Award Terms | Second tranche; service period 5/1/2025 to 5/1/2026 | [4] | ||||||||||||||||
| Expense | $ 88,301 | [4] | ||||||||||||||||
| Dale Ludwig [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | ||||||||||||||||||
| Shares | shares | [4] | |||||||||||||||||
| Grant Date | [4] | |||||||||||||||||
| Stock price | $ / shares | [4] | |||||||||||||||||
| Grant-Date Fair Value | $ 60,000 | [4] | ||||||||||||||||
| Service Period / Award Terms | Third tranche fixed-dollar award for service period; 5/1/2026 to 4/30/2027. Shares not issued as of 6/30/2026 | [4] | ||||||||||||||||
| Expense | $ 10,027 | [4] | ||||||||||||||||
| Aegis Ventures Limited [Member] | ||||||||||||||||||
| Shares | shares | 4,656,550 | [5] | ||||||||||||||||
| Grant Date | Jan. 02, 2025 | [5] | ||||||||||||||||
| Stock price | $ / shares | $ 0.1600 | [5] | ||||||||||||||||
| Grant-Date Fair Value | $ 745,048 | [5] | ||||||||||||||||
| Service Period / Award Terms | Issued in advance of service period; 1/1/2025 to 12/31/2025 | [5] | ||||||||||||||||
| Expense | $ 375,586 | [5] | ||||||||||||||||
| Christopher David Poorman [Member] | ||||||||||||||||||
| Shares | shares | 165,631 | [6] | ||||||||||||||||
| Grant Date | Feb. 19, 2026 | [6] | ||||||||||||||||
| Stock price | $ / shares | $ 0.0483 | [6] | ||||||||||||||||
| Grant-Date Fair Value | $ 8,000 | [6] | ||||||||||||||||
| Service Period / Award Terms | Issued in advance of service period 1/2/2026 to 12/31/2026 | [6] | ||||||||||||||||
| Expense | $ 3,956 | [6] | ||||||||||||||||
| Technologies Apex LLC [Member] | ||||||||||||||||||
| Shares | shares | 3,975,155 | [7] | ||||||||||||||||
| Grant Date | Feb. 19, 2026 | [7] | ||||||||||||||||
| Stock price | $ / shares | $ 0.0483 | [7] | ||||||||||||||||
| Grant-Date Fair Value | $ 192,000 | [7] | ||||||||||||||||
| Service Period / Award Terms | Issued in advance of service period 1/2/2026 to 1/1/2028 | [7] | ||||||||||||||||
| Expense | $ 47,407 | [7] | ||||||||||||||||
| Michelle Yanez [Member] | ||||||||||||||||||
| Shares | shares | [8] | |||||||||||||||||
| Grant Date | [8] | |||||||||||||||||
| Stock price | $ / shares | [8] | |||||||||||||||||
| Grant-Date Fair Value | $ 19,000 | [8] | ||||||||||||||||
| Service Period / Award Terms | Expense related to service period; 3/1/2026 to 6/30/2026. Shares not issued as of 6/30/2026 | [8] | ||||||||||||||||
| Expense | $ 19,000 | [8] | ||||||||||||||||
| ||||||||||||||||||